A new study reveals the potential of a newly designed silicon-rhodamine-based photosensitizer to be used in photodynamic cancer treatment.
Finding viable treatments for cancer is of paramount importance in the medical community. Researchers at Zhengzhou University, led by Yuanqiang Sun, designed a novel silicon-rhodamine-based photosensitizer, SiR-PXZ (1). The initial results and operability of the SiR-PXZ photosensitizer was revealed at length in the journal Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy (1).
Silicon-xanthene derivatives (SiXs) have garnered attention for their promising far-red to near-infrared (NIR) absorption and emission wavelengths, brightness, mitochondrial targeting properties, and high photo-stability (1). However, their potential as photosensitizers (PSs) for photodynamic therapy (PDT) in cancer treatment had been hindered by limited reactive oxygen species (ROS) generation (1). Sun and his team designed SiR-PXZ to specifically address PDT in anticancer treatment using a unique spin–orbit charge transfer-induced intersystem crossing (SOCT-ISC) mechanism (1).
The study revealed that SiR-PXZ possesses several important features. It has biocompatibility, minimal dark toxicity, favorable water-solubility, and stability (1). The photosensitizer demonstrates a considerable singlet oxygen quantum yield under 660 nm light irradiation, which is important to treat cancer as effectively as possible (ΦΔ = 0.16 in air-saturated PBS) (1). The SiR-PXZ is designed to target the mitochondria and induce apoptosis in cancer cells with an IC50 value of 1.2 μM (1). The results demonstrated that SiR-PXZ has powerful anti-tumor effects, which were revealed in the in vivo studies. As a result, SiR-PXZ is a potential candidate for future clinical applications in cancer therapy (1).
The SiR-PXZ photosensitizer is also unique because of its design. By overcoming the limitations in generating cytotoxic ROS, the researchers have opened new avenues for the application of silicon-xanthene derivatives in cancer treatment (1). It underscores how SiR-PXZ could be used in the future for clinical translation. The possibility for SiR-PXZ to be used for this purpose is further validated by the sensor’s heavy-atom-free nature and its targeting properties (1).
Sun and his team used their new sensor to learn more about how to effectively detect and treat cancer. The findings in this study not only contribute to our understanding of silicon-xanthene derivatives but also pave the way for further developments in the field of photodynamic cancer treatment (1).
This article was written with the help of artificial intelligence and has been edited to ensure accuracy and clarity. You can read more about our policy for using AI here.
(1) Zhang, H.; Ren, G.; Hou, W.; Wang, L.; Sun, Y. A Silicon-Rhodamine-Based Heavy-Atom-Free Photosensitizer for Mitochondria-targeted Photodynamic Therapy. Spectrochimica Acta Part A: Mol. Biomol. Spectrosc. 2024, 308, 123688. DOI: 10.1016/j.saa.2023.123688
Getting accurate IR spectra on monolayer of molecules
April 18th 2024Creating uniform and repeatable monolayers is incredibly important for both scientific pursuits as well as the manufacturing of products in semiconductor, biotechnology, and. other industries. However, measuring monolayers and functionalized surfaces directly is. difficult, and many rely on a variety of characterization techniques that when used together can provide some degree of confidence. By combining non-contact atomic force microscopy (AFM) and IR spectroscopy, IR PiFM provides sensitive and accurate analysis of sub-monolayer of molecules without the concern of tip-sample cross contamination. Dr. Sung Park, Molecular Vista, joined Spectroscopy to provide insights on how IR PiFM can acquire IR signature of monolayer films due to its unique implementation.
New Probes for NIR Monitoring of Polymer Injection Molding Composition in Real-Time
May 2nd 2024Researchers from Kyoto University and Japan's National Institute of Advanced Industrial Science and Technology have developed innovative probes to monitor the chemical composition of biodegradable polymer blends during injection molding. This breakthrough could lead to improved production efficiency and reduced waste in the polymer industry.